News

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
Novo Nordisk just killed its deal with Hims & Hers. But Hims might come out stronger after this development. Read why the ...
As you look at the stock markets around the world, it’s always a balance of trying to decide when is the right time to buy.
Gyre Therapeutics has a unique business model for evaluating and commercializing drugs in China. Find out why GYRE stock is a ...